Company / Working Capital
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Working Capital History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$312.3K
FY2015
5-year range
$79.0K / $1.5M
FY2011-FY2015
Trend
+32.2%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $1M to $312,333 over the past 3 years.
Based on SEC 10-K filings.
$312,333 in FY2015 with a 3-year CAGR of -40.6%.
Declined from $1M to $312,333 over the past 3 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -40.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -40.6%, indicating a declining trend.
- In FY2015, working capital increased 32.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $312.3K | +32.2% |
| FY2013 | $236.3K | -84.2% |
| FY2012 | $1.5M | +1787.9% |
| FY2011 | $79.0K | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026